Neoadjuvant nivolumab and ipilimumab for clinical stage III melanoma: Real world outcomes from a community cancer center

Surgical Oncology Insight · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles